OpenURL Connection Search

Select item for more details and to access through your institution.

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Published in:
Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45358-0
By:
- Bol, Kalijn F.;
- Schreibelt, Gerty;
- Bloemendal, Martine;
- van Willigen, Wouter W.;
- Hins-de Bree, Simone;
- de Goede, Anna L.;
- de Boer, Annemiek J.;
- Bos, Kevin J. H.;
- Duiveman-de Boer, Tjitske;
- Olde Nordkamp, Michel A. M.;
- van Oorschot, Tom G. M.;
- Popelier, Carlijn J.;
- Pots, Jeanne M.;
- Scharenborg, Nicole M.;
- van de Rakt, Mandy W. M. M.;
- de Ruiter, Valeska;
- van Meeteren, Wilmy S.;
- van Rossum, Michelle M.;
- Croockewit, Sandra J.;
- Koeneman, Bouke J.
Publication type:
Article
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E<sub>2</sub> results in high interleukin-12 production and cell migration.
Published in:
Cancer Immunology, Immunotherapy, 2008, v. 57, n. 11, p. 1589, doi. 10.1007/s00262-008-0489-2
By:
- Boullart, A. C. Inge;
- Aarntzen, Erik H. J.;
- Verdijk, Pauline;
- Jacobs, Joannes F. M.;
- Schuurhuis, Danita H.;
- Benitez-Ribas, Daniel;
- Schreibelt, Gerty;
- van de Rakt, Mandy W. M. M.;
- Scharenborg, Nicole M.;
- de Boer, Annemiek;
- Kramer, Matthijs;
- Figdor, Carl G.;
- Punt, Cornelis J. A.;
- Adema, Gosse J.;
- de Vries, I. Jolanda M.
Publication type:
Article
A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.
Published in:
2010
By:
- Lesterhuis, W. J.;
- de Vries, I. J. M.;
- Aarntzen, E. A.;
- de Boer, A.;
- Scharenborg, N. M.;
- van de Rakt, M.;
- van Spronsen, D.-J.;
- Preijers, F. W.;
- Figdor, C. G.;
- Adema, G. J.;
- Punt, C. J. A.
Publication type:
journal article

Found: 3

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E<sub>2</sub> results in high interleukin-12 production and cell migration.

A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients.